Abstract
The efficacy of low temperature plasma generated by an atmospheric pressure plasma jet, J‐Plasma system (™Bovie Medical Corporation), is studied for its therapeutic effects against the DU145 prostate cancer cell line. The DU145 cells in complete culture media were treated with different exposure times and different J‐Plasma system parameters. The optimum settings of the J‐Plasma system were identified based on the cancer cell viability at 0, 12, 24, 48, and 72 h post‐low temperature plasma treatments. The results indicate that J‐Plasma killing and cell viability was exposure time dependent and induced a reduction in cell proliferation and delayed killing effect.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
